Omicron is here - what has omicron and the other VOCs taught us so far?
SARS-CoV-2 will continue to mutate its RBD and evade RBD-focused immunity, vaccines and monoclonal antibody therapies. (1/n)
The Lauffenburger Lab is looking to hire an experimental post doc! Our lab is made up of an awesome and supportive community of scientists and engineers-- all it's missing is YOU!!! Please RT! @MITdeptofBE#systemsbiology#systemsimmunology
Really excited to see our paper out in @CellSystemsCP! Thanks to @carolin_loos, Daniil Pokrovsky, @BMC_cores, Ralph Rupp and @MarrCarsten!
@CellPressNews @ICBmunich
https://t.co/ZMCRw9eNtf
A new @CellCellPress study by Ragon Member Galit Alter shows that it may be the quality, not the quantity, of antibody development and response that helps people survive severe COVID-19.
https://t.co/Wy2LZVRNHg
Excited to share our latest work leveraging RNA velocity! Led by @MariusLange8 and in close collab with @dana_peer, CellRank detects initial&terminal cell populations, predicts fate potentials and visualizes gene expression trends. https://t.co/gLPY9WNTDk
https://t.co/PEjTzd75Xc
Prof Doug Lauffenburger among authors of the study published yesterday in @nature. More info on Lauffenburger Lab research here: https://t.co/uCwekwpznS
Check out our new paper on early antibody features associated with #COVID19 outcome.
1) A minimal set of features able to distinguish groups
2) Shift in spike > nucleoprotein reponses in those who recovered
https://t.co/v96tXjSpt9
Two new studies in macaques offer hope that humans could develop protective immunity against #SARSCOV2, either as the result of a natural infection or by way of a vaccine. @BIDMChealth
Read the research:
👉https://t.co/wunrmsanQC
👉https://t.co/iOxmwfp09S
Happy to share our preprint on #PEtab – a data format for specifying parameter estimation problems in systems biology, already supported by several tools (website: https://t.co/bARDJFOaSU). Many many thanks to all contributors! https://t.co/fSStpFlqag
@GonzaParra_ The 1355 include "884 fatalities in nursing homes that occurred over a period of several weeks and that were announced only today" https://t.co/xHk9ZoNBuI
However, I am not disagreeing with the importance of lock downs
Did you ever wonder how well pathway and transcription factor analysis work for scRNA-seq data? Christian Holland (@mr_netherlands) et al. shed light on this question in our latest preprint [https://t.co/JC8Tz59TKz]. 1/6